Ritalin LA (methylphenidate hydrochloride) — NDC 0078-0371 by Novartis Pharmaceuticals Corporation
Ritalin LA (methylphenidate hydrochloride) — NDC 0078-0371 by Novartis Pharmaceuticals Corporation is one of 9,000 drug products in the NDCLookup dataset. Key details — Brand name: Ritalin LA; Generic name: methylphenidate hydrochloride; Product NDC: 0078-0371.
| Brand name | Ritalin LA |
|---|---|
| Generic name | methylphenidate hydrochloride |
| Product NDC | 0078-0371 |
| Labeler | Novartis Pharmaceuticals Corporation |
| Dosage form | CAPSULE, EXTENDED RELEASE |
| Route | ORAL |
| Active ingredients | METHYLPHENIDATE HYDROCHLORIDE 30 mg/1 |
| Pharmacologic class | Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE] |
| Marketing category | NDA |
| Product type | HUMAN PRESCRIPTION DRUG |
| DEA schedule | CII |
| Source | openFDA NDC Directory |
$899/mo
Try NDCLookup →